Recombinant anti-interleukin-9 antibodies
Details for Australian Patent Application No. 2003226065 (hide)
International Classifications
Event Publications
7 August 2003 Complete Application Filed
Priority application(s): 60/371,728 12.04.02 US; 60/371,683 12.04.02 US
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003226065
2 October 2008 Alteration of Name
The name of the applicant has been altered to Ludwig Institute For Cancer Research; MedImmune, LLC
19 February 2009 Alteration of Name
The name of the applicant has been altered to Ludwig Institute for Cancer Research, Ltd; MedImmune, LLC
26 February 2009 Application Accepted
Published as AU-B-2003226065
27 August 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003226066-HEAT EXCHANGE METHOD AND APPARATUS
2003226064-POLYURETHANE OR POLYISOCYANURATE FOAMS BLOWN WITH HYDROFLUOROCARBONS AND CARBON DIOXIDE
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser